Healthcare

Analysis of the United States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023

Technology Advances and New Radiopharmaceuticals Maintain the Industry on a Growth Track

INDUSTRY
Healthcare

RELEASE DATE
06-Mar-2017
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K0A6-01-00-00-00
SKU
HC02728-NA-MR_19502
Yes
SHARE

Analysis of the United States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023
Published on: 06-Mar-2017 | SKU: HC02728-NA-MR_19502

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Molecular imaging can easily be described as the next frontier of medical imaging. In an era of value-based reimbursement, molecular imaging is set to play a significant role in quicker diagnosis, more accurate disease staging, and selection of targeted treatments. Launch of new radiopharmaceuticals across clinical areas other than cardiology and oncology such as neurology and orthopedics is also expected to drive greater adoption of molecular imaging as part of clinical care pathways.

However, molecular imaging continues to face several challenges, notably the high cost of molecular imaging modalities and image scans, competition from lower cost modalities such as CT and MRI, and concerns over future supply of Tc-99m, a key SPECT radiopharmaceutical used for cardiac scans. This study analyzes existing trends in the hybrid molecular imaging and diagnostic radiopharmaceuticals markets with an emphasis on understanding strategies employed by market participants to address these myriad challenges. It also assesses both these markets in the context of changing regulatory and reimbursement policies in order to provide future market trends. This analysis will be critical in helping market participants create long-term viable strategies in order to remain competitive and ensure continuous innovation.

This deliverable assesses future trends in molecular imaging equipment revenues as well as growth in the number of unit shipments over the next few years. This will provide value to market participants that design and manufacture molecular imaging equipment. Market participants will also be provided insights on recent industry and technology trends that are shaping the molecular imaging market. Radiopharmaceutical manufacturers will be provided with key insights on the evolving usage trends of workhorse FDG and Tc-99m radiopharmaceuticals and the increasing adoption of new radiopharmaceuticals across new clinical areas. Companies that are in the process of developing software to improve quantitation accuracy, lower dosages, and reduce scan times for both PET and SPECT will be provided with key insights on how the molecular imaging market is growing as well as the factors that are required to facilitate greater adoption of PET and SPECT technologies.

Research Methodology

Scope of This Study

Key Findings

Market Engineering Measurements—PET/CT

Market Engineering Measurements—SPECT/CT

Market Engineering Measurements—PET/MR

Key Findings

Market Engineering Measurements—PET

Market Engineering Measurements—SPECT

Scope of the Study—Molecular Imaging

Scope of the Study—Radiopharmaceuticals

Molecular Imaging—Segmentation

Molecular Imaging—Definition

Shift in Focus from Standalone to Hybrid Imaging

Radiopharmaceuticals—Definitions

Segmentation of Radiopharmaceuticals

Distribution of Radiopharmaceuticals

US Radiopharmacy Facility Landscape 2016

Market Drivers

Improvements in Quantitation Accuracy

Role of Molecular Imaging in Personalized Medicine

Molecular Imaging Entering Into New Therapeutic Areas

Market Restraints

Affordability of Hybrid Modalities Will Remain Key Issue

Consolidations of Healthcare Providers

Changing Hospital Procurement Models

Market Engineering Measurements

Unit Shipment Forecast

Revenue Forecast

Trend Analysis

Market Share

Market Share Analysis

Market Engineering Measurements

Unit Shipment Forecast

Revenue Forecast

Trend Analysis

Market Share

Market Share Analysis

Market Engineering Measurements

Unit Shipment Forecast

Revenue Forecast

Trend Analysis

Market Share

Market Share Analysis

Analysis of Hybrid Molecular Imaging Products

Actively Marketed PET/CT Products in 2016

Actively Marketed PET/MR Products in 2016

Actively Marketed SPECT/CT Products in 2016

Digital PET—The Next Chapter in Nuclear Imaging

GE Healthcare—Key Technology Trends

GE Debuts DiscoveryTM MI PET/CT at SNMMI 2016

Launch of Discovery IQ PET/CT by GE

GE Launches First General Purpose Digital SPECT/CT

Siemens Debuts Mobile Biograph Horizon PET/CT

Siemens Debuts Latest Version of syngo.via

NeuSoft

Toshiba America Medical Systems

Molecular Dynamics

UltraSPECT

Upgradeability and Intra Modality Competition

Nuclear Medicine Physicians Face Employment Challenges

Technology Trends—PET/CT & SPECT/CT

Industry Trends—Advancements in Brain Imaging Using SPECT

Industry Trends—PET Scanning and Alzheimer’s Disease

Industry Trends—CMS Approves Funding for PET Amyloid Study

Industry Trends—Myocardial Perfusion Imaging: PET vs. SPECT

Market Drivers

Development of New Radiopharmaceuticals

Adopting a Cyclotron-based Approach

Mo-99 Production—Key Challenges and Potential Solutions

Market Restraints

Pricing and Reimbursement of Tc-99m—Key Challenges

High Entry Barriers Limit the Number of Participants

Market Engineering Measurements

Procedure Forecast

Revenue Forecast

Trend Analysis

Market Share

Market Share Analysis

Market Engineering Measurements

Procedure Forecast

Revenue Forecast

Trend Analysis

Market Share

Market Share Analysis

Analysis of PET and SPECT Radiopharmaceuticals

Key Market Participants and Main Product Lines

Siemens PETNET

IBA Molecular

Ionetix

Jubilant Draximage Develops Rubidium Generator

Northstar Medical Isotopes to Produce Mo-99

FDA Approves Gallium 68 Dotatate Kit—NETSPOT

FDA Approves Axumin PET Radiopharmaceutical

Axumin—Safety and Efficacy Parameters

CMS Rejection of NaF—18 PET Scan Reimbursement

Cardiac PET Perfusion Agents Industry—A Snapshot

Role of Radiopharmaceuticals in Oncology Clinical Trials

18F-CFA—The Next Frontier in Cancer Treatment

New PET Tracers for Clinical Use in Oncology

The Last Word—3 Big Predictions: Molecular Imaging

The Last Word—3 Big Predictions: Radiopharmaceuticals

Legal Disclaimer

Glossary of Terms—Molecular Imaging

Glossary of Terms—Radiopharmaceuticals

Market Engineering Methodology

Reimbursement of Procedures Involving Use of Radiopharmaceuticals and Molecular Imaging Modalities

Reimbursed Radiopharmaceuticals Billing Codes

List of Figures
  • 1. Total Molecular Imaging Equipment Market: Key Market Drivers, US, 2017–2023
  • 2. Total Molecular Imaging Equipment Market: Key Market Restraints, US, 2017–2023
  • 3. PET/CT Equipment Segment: Market Engineering Measurements, US, 2016
  • 4. SPECT/CT Equipment Segment: Market Engineering Measurements, US, 2016
  • 5. PET/MR Equipment Segment: Market Engineering Measurements, US, 2016
  • 6. Total Radiopharmaceuticals Market: Key Market Drivers, US, 2017–2023
  • 7. Total Radiopharmaceuticals Market: Key Market Restraints, US, 2017–2023
  • 8. PET Radiopharmaceuticals Segment: Market Engineering Measurements, US, 2016
  • 9. SPECT Radiopharmaceuticals Segment: Market Engineering Measurements, US, 2016
List of Charts
  • 1. PET/CT Equipment Segment: Market Engineering Measurements, US, 2016
  • 2. SPECT/CT Equipment Segment: Market Engineering Measurements, US, 2016
  • 3. PET/MR Equipment Segment: Market Engineering Measurements, US, 2016
  • 4. PET Radiopharmaceuticals Segment: Market Engineering Measurements, US, 2016
  • 5. SPECT Radiopharmaceuticals Segment: Market Engineering Measurements, US, 2016
  • 6. PET/CT Equipment Segment: Unit Shipment Forecast, US, 2013–2023
  • 7. PET/CT Equipment Segment: Revenue Forecast, US, 2013–2023
  • 8. PET/CT Equipment Segment: Percent of Sales, US, 2016
  • 9. SPECT/CT Equipment Segment: Unit Shipment Forecast, US, 2013-2023
  • 10. SPECT/CT Equipment Segment: Revenue Forecast, US, 2013–2023
  • 11. SPECT/CT Equipment Segment: Percent of Sales, US, 2016
  • 12. PET/MR Equipment Segment: Unit Shipment Forecast, US, 2013–2023
  • 13. PET/MR Equipment Segment: Revenue Forecast, US, 2013–2023
  • 14. PET/MR Equipment Segment: Percent of Sales, US, 2016
  • 15. PET Radiopharmaceuticals Segment: Procedure Forecast, US, 2013–2023
  • 16. PET Radiopharmaceuticals Segment: Revenue Forecast, US, 2013-2023
  • 17. PET Radiopharmaceuticals Segment: Percent of Sales, US, 2016
  • 18. SPECT Radiopharmaceuticals Segment: Procedure Forecast, US, 2013–2023
  • 19. SPECT Radiopharmaceuticals Segment: Revenue Forecast, US, 2013–2023
  • 20. SPECT Radiopharmaceuticals Segment: Percent of Sales, US, 2016

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Medical Imaging & Informatics research

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

26 Oct 2026   |   Global   |   Technology Research

Game-Changing Innovations Transforming Cardiovascular Care

The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...

23 Oct 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...

07 Oct 2026   |   Global   |   Technology Research

Growth Opportunities in Image-Guided Cancer Ablation Systems

Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...

05 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Point-of-Care Ultrasound Imaging Technology Ecosystem, 2026

The point-of-care ultrasound imaging industry is undergoing a fundamental transformation from equipment-intensive ultrasound to portable, handheld, wireless, AI-enabled, and connected point-of-care solutions. Driven by the need for rapid bedside diagnosis and decentralized healthcare delivery, speci...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.